Photomontage of the lesion prior to (A) and after (B) the development of a relative afferent pupillar defect(RAPD) in monkey 89-135/R99-41 with overlay of a template of retinal ganglion cell density isocontours by Perry and Cowey.11 Prior to the development of an RAPD, the size of the lesion was 5.82 mm2 with a predicted percent ganglion cell loss of 8.9% to 11.1% (Table 2). After the development of an RAPD, the size of the lesion was 37.66 mm2 with a predicted percent ganglion cell loss of 29.8% to 37.2%. The actual percent ganglion cell loss was 43.2%.
Pupil recording from monkey 89-140/R99-42(examination 1) after detection of a 0.6 log unit relative afferent pupillary defect in the right eye on clinical examination. The tracing on the left is performed during stimulation of the left eye for 2 seconds (horizontal bar) with a mini-Ganzfeld stimulus while recording from the right eye. The tracing on the right is performed while stimulating the right eye and recording from the left eye.
Histopathologic analysis of the retina and optic nerve from monkey 89-126/R99-27 (hematoxylin-eosin). A, Within the macula, there was complete loss of the normal retinal architecture (original magnification ×25). The retina was replaced by avascular tissue composed of glial cells and pigmented macrophages (arrows). A focal, thin preretinal membrane was present overlying the scar (arrowheads). The retinal pigment epithelium was absent in the area of the scar. The underlying choroid was thickened with pigmented cells (asterisks). B, The temporal aspect of the optic nerve was atrophic (arrowheads) with thinning of the temporal nerve fiber layer (original magnification ×10). For an area extending approximately 18
mm on either side of the scar, there was loss of the photoreceptor layer with some remaining cells in the inner nuclear and ganglion cell layers. C, Microscopic examination of right optic nerve cross sections (original magnification ×10) disclosed a C-shaped area of atrophy (between arrowheads) temporally with vacuolization of the nerve fiber bundles and gliosis.
Right optic nerve (monkey 89-140). A, Injured area demonstrates mostly degenerating myelin profiles (arrow) and glial cells (asterisk). Some residual normal myelinated axons (arrowhead) are present, particularly at the margin of injury, as in this area. B, Normal area demonstrates well-formed myelinated axons (arrowhead) (toluidine blue, original magnification ×400).
Graph of axonal diameters of treated right and untreated left eyes.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Kerrison JB, Buchanan K, Rosenberg ML, Clark R, Andreason K, Alfaro DV, Grossniklaus HE, Kerrigan-Baumrind LA, Kerrigan DF, Miller NR, Quigley HA. Quantification of Optic Nerve Axon Loss Associated With a Relative Afferent Pupillary Defect in the Monkey. Arch Ophthalmol. 2001;119(9):1333–1341. doi:10.1001/archopht.119.9.1333
Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2001
To quantify the amount of optic nerve axonal loss associated with the presence of a mild relative afferent pupillary defect (RAPD) in an experimental monkey model.
The right macula of 5 rhesus monkeys (Macaca mulatta) was treated with concentrically enlarging diode laser burns until an RAPD was detected using a transilluminator light and measured with neutral density filters. Intervals between treatments were 3 to 7 days over a period of 2 months. Pupillary responses to light stimulation were recorded with a monocular infrared television pupillometer. Two months after detection of an RAPD, 5 treated and 4 control monkeys underwent euthanasia and enucleation. Histopathologic analysis and quantification of optic nerve axon counts using an image analysis system were performed.
No RAPD was observed despite an estimated ganglion cell loss of up to 26%. A 0.6 log unit RAPD was present in 5 monkeys when the laser scar incorporated the entire macula within the temporal vascular arcades. One eye had progressive vitreomacular traction with worsening of the RAPD to 1.8 log units without further laser treatment. Histopathologic evaluation disclosed complete loss of the normal retinal architecture within the macula. The average fiber loss for the 4 treated eyes with 0.6 log unit RAPDs compared with fellow eyes was 53.3% (95% confidence interval [CI], 45.0%-61.6%). The average difference in axon counts between untreated pairs of optic nerves was 12.8% (95% CI, 10.0%-15.6%). Optic nerve axon loss between pairs of experimental and control eyes was statistically significant (P<.001).
In rhesus monkeys, an RAPD develops after an approximate unilateral loss between 25% and 50% of retinal ganglion cells.
Owing to redundancy in the anterior visual pathways, unilateral retinal ganglion cell loss may occur prior to the observation of an RAPD. The presence of an RAPD measuring 0.6 log units implies that significant retinal ganglion cell injury has occurred.
ASSESSMENT OF the pupillary reaction to light is one of the few tests of visual function that does not require a subjective patient response. Detection of abnormalities in the pupillary light reflex is performed by alternately illuminating each eye while comparing the velocity and amplitude of the pupillary responses.1,2 Asymmetry in this response is referred to as a relative afferent pupillary defect (RAPD) and indicates either unilateral or bilateral asymmetric disease of the anterior visual system.
An RAPD can be quantified by sequentially placing optical filters of increasing density in front of the normal eye as a light source alternately illuminates each eye.3 These filters logarithmically reduce the light input into the normal eye until the pupillary responses are symmetric. Using this technique, the severity of an RAPD can be quantified as the density of the filter required to balance the response of each eye, ranging from 0.3 to 3.0 log units. While an RAPD measuring 0.3 to 0.6 log units might clinically be considered to be within the mild spectrum of disease, it represents a 50% to 87% decrement in light input, respectively.
Although the severity of an RAPD does not correlate with reduction in visual acuity, it does correlate with the visual field loss4-6 and the anatomic extent of retinal disease.7-9 Despite the fundamental clinical importance of the RAPD in assessment of visual function, it is not known how much optic nerve damage is present when one observes an RAPD. The present study quantified the amount of axon loss associated with the presence of a 0.6 log unit RAPD in an experimental animal model (rhesus monkey) of retinal nerve fiber loss produced by unilateral retinal laser photocoagulation.10
Rhesus monkeys (Macaca mulatta) were chosen for use in this study because their eyes closely resemble the human eye in foveal structure, pigmentation, and the pupillary response to light. They were anesthetized and handled for treatment, photography, pupillography, and euthanasia in accordance with standards established by the Association for Research in Vision and Ophthalmology (Rockville, Md) resolution on Use of Animals in Research and US Department of Defense guidelines. Based on 3 prior unpublished observations (Dr Quigley, unpublished data, 1990), the number of axons between monkey eyes can vary by 10%. We estimated the need to treat between 4 and 5 monkeys to detect at least a 20% difference in axonal counts. Prior to laser treatment, all animals underwent eye examination with a hand light, clinical assessment of the pupillary response, measurement of intraocular pressures, dilated fundus examination, and fundus photography using a Kowa fundus camera (Kowa, Torrance, Calif). All monkeys participating in the study had normal findings on eye examination prior to inclusion. Sedation consisted of intramuscular injection of ketamine (10 mg/kg) using a 25-gauge needle. The monkeys were then placed in primate restraint chairs as a means of stabilizing the head.
Following baseline pupillometric recording from all animals, the right eye was dilated with 2.5% phenylephrine and 1% tropicamide. The treatment protocol was initiated with an approximately 800-µm laser lesion centered on the nasal aspect of the foveal depression in the papillomacular bundle of the right eye. The laser consisted of an Oculight Diode Laser (Iris Medical Instruments Inc, Mountain View, Calif) administered through an indirect ophthalmoscope delivery system. The laser emission was approximately 810 nm in the infrared part of the optical spectrum. The spot size was 500 µm with duration ranging from 400 to 600 milliseconds and power ranging from 340 to 810 mW. To ensure damage to the ganglion cell and nerve fiber layers, treatments were repeated and intense. Between 2 and 5 days following each treatment, the eyes were examined clinically for the presence of an RAPD. If an RAPD was not present, the eyes were dilated and further laser emissions were administered to the prior treatment area followed by concentric expansion around the lesion. Once the nasal aspect of the lesion reached the optic nerve, the lesion was expanded temporally.
Fundus photography was performed periodically. Images were digitized and a photomontage created (Adobe Photoshop 4.0; Adobe Systems Inc, San Jose, Calif). A map of retinal ganglion cell isodensities from monkey eyes published by Perry and Cowey11 was projected onto each retinal photomontage (Figure 1). This template was referenced to the horizontal diameter of the optic nerve determined in the pupil/optic nerve head histopathologic sections. The area of scarring within each isodensity contour line was outlined and measured using computer software that allows one to capture, display, analyze, and measure images (Scion Image; Scion Corp, Frederick, Md). This area was multiplied by the ganglion cell density for that isocontour. The total estimated ganglion cell loss was the sum of the estimated ganglion cell loss for each area.
Clinical testing for the presence of an RAPD was performed under ketamine sedation in darkness using a transilluminator light (Welch-Allyn, Skaneateles Falls, NY), illuminating each eye separately while assessing the pupillary response for asymmetry. The transilluminator used a 3.5 V halogen bulb. Following this, the light was alternated back and forth at varying intervals between 1 and 3 seconds. If asymmetry in the pupillary responses was observed, neutral density filters of increasing density were placed in front of the untreated eye while the light was once again alternated back and forth. The density of the filter was recorded when the pupillary responses were symmetric. Pupil recordings were performed in treated monkeys with a monocular infrared television pupillometer (Eye Scan Inc, Burlington, Mass). The source of light photostimulation was a handheld mini-Ganzfeld photostimulator (LKC Technologies Inc, Gaithersburg, Md). The photostimulator provided a square-wave stimulation of 13 candela(cd)/mm2 as a 2-second pulse or continuous mode, the signal for which was output to the pupillometer.
The recording protocol consisted of illuminating 1 eye while recording the response from the fellow eye in the darkened room. The mini-Ganzfeld photostimulator was used to stimulate an eye for 2 seconds at 3- to 5-second intervals. The photostimulator output signaled to the computer the onset and cessation of the stimulus. Each trial consisted of 6 to 9 stimulations. After a trial, several minutes were allowed to elapse in darkness before conducting another trial. Each eye underwent 3 to 6 trials. The constriction amplitudes were averaged for each eye at examinations performed at the initial observation of an RAPD and 2 weeks later.
For euthanasia, monkeys were administered intramuscular ketamine (10 mg/kg) in the caudal thigh muscle using a 25-gauge needle, followed by intravenous pentobarbital sodium via the lateral saphenous vein using a 23-gauge needle. Perfusion fixation was performed after exsanguination through an incision in the femoral artery. An abdominal incision was performed with isolation of the descending aorta approximately 3 inches prior to the bifurcation. A 14-gauge cannula was inserted into the aorta, and a preplaced 4-0 silk suture was tied. After clearing the line with heparinized isotonic sodium chloride solution, infusion with 1% procaine/isotonic sodium chloride solution was performed until the blood began to clear. Then, infusion with approximately 2 liters of 4% paraformaldehyde/2% glutformaldehyde in 0.1mM phosphate buffer(pH 7.4) was performed. The eyes and optic nerves were harvested along with other organs.
Following enucleation, globes were placed in fixative after slits were made in the pars plana. The globes were opened by removal of the superior and inferior caps. Pupil/optic nerve sections incorporating the area of laser treatment were prepared and stained with hematoxylin-eosin. Cross sections of the optic nerves were also obtained. A 1-mm thick section of optic nerve was obtained within 3 mm of the posterior surface of the globe and the superior and nasal quadrants marked with single and double razor blade cuts, respectively. These sections were rinsed in cacodylate buffer (pH 7.4), postfixed in 2% osmium tetroxide in cacodylate buffer, dehydrated in alcohol, and embedded in epoxy resin. Cross sections 1-µm thick were cut with an ultramicrotome, mounted on glass slides, and stained with toluidine blue, which allows one to distinguish residual, degenerating myelin bundles from normal ones. Neural bundle areas, from normal profiles, were measured by planimetry on enlarged photographs of each nerve cross section, and each nerve was divided into 16 segments of approximately equal area. Four random 50 × 50 µm areas from each of 16 segments were examined using an image analysis system (Zeiss VIDAS; Carl Zeiss Inc, Thornwood, NY) to determine absolute axon number and fiber diameter. To determine fiber diameter, an algorithm was used by which each myelinated nerve fiber had its geometric center identified and 32 radii drawn to the inner edge of the myelin sheath. The smallest radius was multiplied by 2 to determine the smallest diameter. Fiber diameters were sorted into bins separated by 0.1 µm. Optic nerve axon counts were performed on all specimens and the difference between eyes determined. The difference in axon counts between pairs of eyes from treated monkeys was compared with the difference in axon counts between pairs of eyes from untreated animals using the 2-tailed t test with unequal variance.
Five monkeys received concentrically enlarging diode laser treatments to the macula until an RAPD was detected (Table 1). The amount of treatment varied from 390 to 810 mW delivered between 6 and 11 treatment sessions over the course of 3 months. The number of spots per session varied from 1 to 798, with the total number of spots varying from 2262 to 3378 spots per eye. Four eyes experienced hemorrhaging during laser treatment. Two eyes developed small choroidal hemorrhages that resolved. Two eyes had choroidal hemorrhages with extension into the vitreous following laser-induced breaks in the Bruch membrane. The vitreous hemorrhages cleared over 2 weeks. In 1 eye, vitreomacular traction became apparent on subsequent examinations.
Prior to each successive treatment, the monkeys were examined for the presence of an RAPD. When the treatment area, based on the retinal photomontage, measured an average of 9.43 mm2 (3 monkeys: range, 5.82-14.65 mm2) at the nasal aspect of the foveal depression within the maculopapillary bundle, the pupils of treated and untreated monkeys were examined by an observer(M.L.R.) who was masked to treatment status of the monkey and which eye was treated (Table 2). The observer did not detect an RAPD in any of the monkeys at this stage. Estimation of the retinal ganglion cell death at this time, based on the optic nerve axon counts of untreated eyes in the present study and the projection of monkey retinal ganglion cell isodensity maps11 onto the retinal photomontage, resulted in a mean estimated percent ganglion cell loss of 16.5% (range, 11.1%-26.0%) (Table 2).
When the lasered area incorporated the entire area within the arcades, a 0.6 log unit RAPD was detected in the treated eye of 5 monkeys (Table 1). All monkeys were euthanized 2 months after the detection of an RAPD. In 4 monkeys, to destroy any possible remaining ganglion cells within the laser scar, a final laser treatment session was applied only within the previously treated area 1 month prior to euthanasia. At the time of euthanasia, the size of the RAPD remained 0.6 log units in all 4 animals. The treated eye of the fifth monkey, which had experienced a vitreous hemorrhage, had no further photocoagulation. This eye developed worsening vitreomacular traction, and a 1.8 log unit RAPD was detected prior to euthanasia.
Prior to euthanasia, the lesioned area in all the monkeys incorporated the entire macula within the temporal arcades (Figure 1). Based on reconstruction of the retinal photomontage, the lesions measured an average of 39.38 mm2 in 5 monkeys (range, 28.36-47.90 mm2) (Table 2).
Pupillography was performed on 5 lesioned monkeys after initial observation of an RAPD and again 2 weeks later. Technically consistent recordings were obtained after stimulation with the mini-Ganzfeld photostimulator. The amplitude of pupillary constriction was decreased an average of 30% in treated eyes in comparison with untreated eyes (Table 3; Figure 2).
Following enucleation, histopathologic evaluation of treated eyes disclosed complete loss of the normal retinal architecture within the macula (Figure 3A). The retina was replaced by avascular tissue composed of glial cells and pigmented macrophages. A thin preretinal membrane was present overlying the scar. For an area extending approximately 18
mm on either side of the scar, there was loss of the photoreceptor layer with some remaining cells in the inner nuclear and ganglion cell layers. The retinal pigment epithelium was absent in the area of the scar. The underlying choroid was thickened with pigmented cells. The temporal aspect of the optic nerve was atrophic with thinning of the temporal nerve fiber layer. Examination of the optic nerve cross sections disclosed a C-shaped area of atrophy with vacuolization of the nerve fiber bundles and gliosis (Figure 3C). Optic nerve cross sections stained with toluidine blue demonstrated some residual degenerating myelin bundles (Figure 4).
Quantification of axon loss between eyes in experimental monkeys and control monkeys demonstrated a significant axon loss in treated eyes (Table 4). The mean ± SD fiber loss for the 4 treated eyes with 0.6 log unit RAPDs in comparison with fellow eyes was 53.3% ± 8.0% (95% CI, 45.0%-61.6%). Compared with the difference between pairs of untreated eyes of 4 control monkeys, this loss significantly exceeded the normal intereye difference in axon counts of 12.8% ± 2.8%(95% CI, 10.0%-15.6%) (P<.001, 2-tailed t test). Axon loss was greatest in the temporal sector of the optic nerve (Table 5; Figure 3). Estimation of the retinal ganglion cell death prior to euthanasia based on projection of monkey retinal ganglion cell isodensity maps of Perry and Cowey11 onto the retinal photomontage resulted ina mean estimated percent ganglion cell loss of 30.0% (range, 24.8%-35.3%) (Table 2), lower than what was observed for axon counts.
Comparison of mean axonal diameters between pairs of eyes in treated monkeys and pairs of eyes in untreated monkeys demonstrated no significant difference (Table 4). The distribution of the diameters for treated and untreated eyes was similar (Figure 5).
The principal finding of this study is that an RAPD, measuring 0.6 log units, developed after an approximate loss of between 25% and 50% of retinal ganglion cells. To determine the amount of retinal ganglion cell loss using the present model, full-thickness destruction of the retina within a circumscribed area had to be achieved followed by an adequate interval of time for ascending atrophy to take place. Complete destruction of all retinal layers was achieved by repeated laser treatments and confirmed by histopathologic examination. The area of injury was essentially confined to the treatment area as only a thin rim of outer retinal injury, with some remaining inner nuclear and ganglion cell layers was present. The monkeys underwent euthanasia 2 months after the detection of an RAPD. To ensure complete destruction within the scar, the previously treated area was retreated 4 weeks prior to euthanasia. In the squirrel monkey, Anderson12 observed that atrophy occurs in the distal axon segment following retinal photocoagulation between 2 and 4 weeks after injury. Four weeks following retinal laser treatment, most of the axon debris had cleared without the appearance of phagocytes.12 In the present study, the prior heavy treatment within the laser scar over the preceding months, the lack of a change in the RAPD prior to euthanasia, and the ability to distinguish residual degenerating neural bundle profiles from normal profiles in axon counting suggest that theinterval between treatment and euthanasia was adequate and did not result in an underestimation of the extent of damage. Thus, the optic nerve axon counts accurately reflect the extent of terminal ganglion cell injury at the time of euthanasia.
Ganglion cell injury beyond the area of treatment may have occurred from either damage to the nerve fibers passing through the treated area or from secondary injury.13-16 Although damage to axon processes passing though the treatment area with subsequent descending atrophy may have occurred, this was minimized by expanding the lesion temporally rather than superiorly and inferiorly. In addition, one would expect injury of axons passing through the lesion to be reflected in both the pupillary responses and axon counts. Secondary retinal ganglion cell damage, possibly mediated through glutamate excitotoxicity outside the laser treatment area, may also have occurred. It is difficult to estimate the role this may have played. If the effect was progressive following injury, it was not large enough to alter the size of the RAPD over 8 weeks. If secondary injury took place simultaneous to primary death of the retinal ganglion cells that were photocoagulated, its effect would be expected to be observed in both the pupillary responses and in the axon counts.
Overlay of the retinal ganglion cell templates on the retinal photographs resulted in an underestimation of axon loss in comparison with postmortem axon counts. This may be owing to loss of retinal ganglion cells outside the treatment area as discussed or underestimation of the density of retinal ganglion cells in these templates.
This model, in which ganglion cell loss was associated with outer retinal damage, differs from most clinical optic neuropathies in which damage is generally isolated to the retinal ganglion cell and nerve fiber layers. The particular advantage of the present model is that it allowed ganglion cell damage to take place in a controlled, graded manner followed by pupil examination. For the present model to be compared with clinically encountered optic neuropathies, it is assumed that photoreceptors within a scotoma do not contribute significant pupillomotor input through lateral transmission of impulses to regions outside the scotoma.
In humans, RAPDs of 0.3 log units can easily be detected, and defects as small as 0.1 log units can be measured using cross-polarizing filters. Good correlation has been demonstrated between intraobserver clinical measurements as well as between clinical measurement17 and automated infrared pupillometry.18 In the present study, pupillary responses were assessed both clinically and using infrared pupillometry. Assessment of the pupillary responses in this study was performed while these monkeys were sedated with ketamine. Although this may have influenced the pupillary response, we would expect the response of each eye to be equally affected; hence, this would not impair our ability to identify a difference.
Regarding clinical assessment, a 0.6 log unit deficit was the smallest RAPD that could be reliably detected in any of the monkeys. The development of a 0.6 log unit RAPD in the setting of significant injury may reflect a threshold effect with regard to ganglion cell loss and pupillary responses, or it may be secondary to technical factors. In humans, the ability to detect subtle abnormalities with the alternating flashlight test is highly dependent on timing. We suspect that the responses of the monkey pupil are different from human responses in that they have a shorter latency and a more rapid recovery phase. Thus, the most sensitive testing paradigm for detecting an RAPD in humans may be different from that used in monkeys.
In humans, the RAPD correlates with the anatomic extent of retinal damage in macular degeneration9 and retinal detachment.7,8 In patients with macular degeneration, an RAPD is observed most often with disciform scars larger than 6 disc diameters.9 In one study of RAPDs in retinal detachments, each peripheral quadrant of detachment contributed to 0.35 log units of defect, whereas detachment of the macula caused an additional 0.68 log units.8 In another study of retinal detachments, abnormal pupillary responses were uncommon in peripheral detachments and occurred in approximately half of the detachments involving the macula.7
Although the depth of an RAPD does not correlate with visual acuity, it does correlate with the extent of visual field loss.4-6 The correlation between the RAPD and static threshold as measured by perimetry5,6 is consistent with the observation that the light reflex is only 0.2 log units above the threshold for light perception19 and closer to the threshold for light perception with larger areas of stimulation.20 Visual fields have been used to estimate the amount of ganglion cell loss in association with RAPDs by superimposing templates of human ganglion cell densities21 over visual fields. A linear correlation was observed, which predicted that a 0.6 log unit RAPD would be associated with an estimated ganglion cell loss of between 6% and 18%. However, the authors acknowledged that these results should be interpreted with caution because the study was unable to account for the presence of relative scotomas and did not take into account the observation of other investigators that the relationship between ganglion cell loss and visual field loss has been observed to be nonlinear.22-24
Bilateral quantification of optic nerve axon loss in humans with RAPDs has been performed. In these cases, the axon loss was severe and bilateral, but asymmetric. For example, in a case of bilateral anterior ischemic optic neuropathy, the axon counts were reduced to 4% of normal in one eye and 28% of normal in the other eye.25 In 3 cases with compressive lesions of the anterior visual pathways and RAPDs, the reduction in optic nerve axons, compared with normal optic nerves, was 30% and 70%, 9% and 32%, and 0% and 3% (right and left eyes).26 Thus, in the setting of bilateral optic neuropathies, an RAPD may be present with an estimated retinal ganglion cell reduction by as much as 57% in one eye compared with the other. Although RAPDs were present in these cases, the severity of the RAPDs was not quantified.
Although our study does not demonstrate the retinal ganglion cell loss that is sufficient to produce the minimum clinically detectable RAPD of 0.3 log units, it does demonstrate that an RAPD developed when retinal ganglion cell loss was between approximately 25% and 50%. This would be consistent with a threshold effect regarding estimated ganglion cell loss and central visual function. A threshold effect may be observed owing to an exponential relationship between ganglion cell loss and visual function or a limit beyond which this relationship is linear. A nonlinear relationship has been observed with regard to visual acuity27-29 and visual fields.22-24 Taken together, these studies imply that disease may affect retinal ganglion cells prior to a significant decrease in visual acuity, a mild abnormality on visual field testing, or a mild RAPD.
A threshold effect with regard to retinal ganglion cell damage and the RAPD may be explained by redundancy in the anterior visual pathways. The neuroanatomic substrate for this redundancy may be overlapping receptive fields.30,31 The relationship between visual function and retinal ganglion cell loss may be influenced by receptive field size and overlap as well as by the pattern of retinal ganglion cell loss, whether it is focal and complete, as in the present study, or diffuse and partial. The receptive field size and overlap varies with the ratio of photoreceptors to retinal ganglion cells, which varies with location (central vs peripheral) and ganglion cell type. The pattern of retinal ganglion cell loss also depends on the pathologic process. Thus, the estimation of retinal ganglion cell loss in association with an RAPD, as determined in the present study, may differ in comparison to another model, such as glaucoma, which results in a different pattern of retinal ganglion cell loss.
These data challenge the hypothesis that a mild asymmetry of 53% of crossed fibers compared with 47% of uncrossed fibers32 underlies the RAPD seen in optic tract injury.33-36 Although asymmetry of fiber crossing at the chiasm is the most plausible explanation for an RAPD with optic tract lesions, as many as 4 other possible explanations are possible: (1) the amount of crossing may be greater than previously estimated,(2) the asymmetry may be greater for pupillomotor fibers,37(3) a functional asymmetry may be present that is not represented in anatomical studies, or (4) additional physiologic processes such as inhibition may be playing a role. Nevertheless, optic tract lesions can be associated with RAPDs of 0.3 log units, and a threshold effect might allow for an RAPD to be present in the setting of small amounts of asymmetric injury to the anterior visual pathways.
We observed that an RAPD developed when retinal ganglion cell loss was between approximately 25% and 50% in rhesus monkeys. To the extent that this may be extrapolated to clinically encountered optic neuropathies, it implies that unilateral retinal ganglion cell damage may occur prior to the development of an RAPD. Furthermore, the presence of a 0.6 log unit RAPD implies significant injury that may have prognostic significance for a patient's ability to recover from future insults.
Accepted for publication February 23, 2001.
This work was supported by a departmental grant, Uniformed Services University of Health Sciences, Bethesda, Md (Dr Kerrison); EY02120, National Eye Institute, Bethesda (Dr Quigley); and EY01765, National Eye Institute(Core Facility Grant, Wilmer Institute).
We thank Anthony C. Kouzis, PhD, of the Wilmer Eye Institute for statistical consultation.
Corresponding author and reprints: John B. Kerrison, MD, Wilford Hall Medical Center, 2200 Bergquist Dr, Suite 1, Lackland AFB, TX 78236 (e-mail: email@example.com).